LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner

Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epitheliu...

Full description

Saved in:
Bibliographic Details
Published inJournal of hematology and oncology Vol. 9; no. 1; p. 117
Main Authors Wang, Wen-Tao, Ye, Hua, Wei, Pan-Pan, Han, Bo-Wei, He, Bo, Chen, Zhen- Hua, Chen, Yue-Qin
Format Journal Article
LanguageEnglish
Published England BioMed Central 03.11.2016
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression. In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging. We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H O and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4. Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA.
AbstractList Abstract Background Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression. Methods In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging. Results We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H2O2 and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4. Conclusions Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA.
Background Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression. Methods In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging. Results We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H2O2 and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4. Conclusions Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA.
BACKGROUNDLong non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression.METHODSIn this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging.RESULTSWe firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H2O2 and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4.CONCLUSIONSOur study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA.
Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression. In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging. We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H O and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4. Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA.
ArticleNumber 117
Author Wei, Pan-Pan
Wang, Wen-Tao
Ye, Hua
Han, Bo-Wei
He, Bo
Chen, Yue-Qin
Chen, Zhen- Hua
Author_xml – sequence: 1
  givenname: Wen-Tao
  surname: Wang
  fullname: Wang, Wen-Tao
– sequence: 2
  givenname: Hua
  surname: Ye
  fullname: Ye, Hua
– sequence: 3
  givenname: Pan-Pan
  surname: Wei
  fullname: Wei, Pan-Pan
– sequence: 4
  givenname: Bo-Wei
  surname: Han
  fullname: Han, Bo-Wei
– sequence: 5
  givenname: Bo
  surname: He
  fullname: He, Bo
– sequence: 6
  givenname: Zhen- Hua
  surname: Chen
  fullname: Chen, Zhen- Hua
– sequence: 7
  givenname: Yue-Qin
  surname: Chen
  fullname: Chen, Yue-Qin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27809873$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAQtVARbRd-ABdkiQuHBmzH-fAFqVrRbqUVSIierYljZ71K7MVOVu0P4H_j7Jaq7QHJX-N573k8M-foxHmnEXpPyWdK6_JLpDnhRUZomZGc1xl5hc5oVZRZXTF28uR8is5j3BJSUsHIG3TKqpqIusrP0J-1Uz-_X0a8ogKDa_Hqdr28wKBGu4dRt7i5x_7OtpBsjeMYdIwXeBf84EeNle57PNguJLd3B751e4izYR1WG9-D66xXEJR1fgA8boKfug2GxE3v4gGc0-Etem2gj_rdw75At1fffi1X2frH9c3ycp2pkokxM0XL0jBtYYxKH9aKE1BVwXjV5IQYDoxSZfLWlIqUShnRABWKz9OIRFmgm6Nu62Erd8EOEO6lBysPFz50EsJoVa8lMa1mlW6J4IYLThsgIteaNoazvNF10vp61NpNzaBbpd0YoH8m-tzj7EZ2fi-LJCTKIgl8ehAI_vek4ygHG-eMgtN-ipLWeVkxwUuWoB9fQLd-Ci6l6oBiBSN8Rn14GtFjKP-qnQD0CFDBxxi0eYRQIueOkseOkqmj5NxRaVmg6gVH2fFQ7vQp2_-H-RepUNEq
CitedBy_id crossref_primary_10_1080_10408398_2021_2001785
crossref_primary_10_1155_2021_7777699
crossref_primary_10_1016_j_gene_2024_148616
crossref_primary_10_3892_wasj_2019_18
crossref_primary_10_3390_ncrna8060072
crossref_primary_10_3892_ijmm_2018_3457
crossref_primary_10_1155_2020_3035624
crossref_primary_10_1080_15384101_2019_1593647
crossref_primary_10_1007_s00011_017_1035_5
crossref_primary_10_1016_j_omtn_2019_11_031
crossref_primary_10_1016_j_omtn_2019_11_028
crossref_primary_10_1186_s12943_018_0879_9
crossref_primary_10_1080_15376516_2023_2197489
crossref_primary_10_1186_s12964_018_0271_9
crossref_primary_10_1016_j_biopha_2020_109916
crossref_primary_10_1093_bfgp_elaa026
crossref_primary_10_1089_ars_2017_7276
crossref_primary_10_1186_s12920_018_0465_4
crossref_primary_10_3390_ncrna9020019
crossref_primary_10_1016_j_biopha_2020_110228
crossref_primary_10_1016_j_omtn_2018_04_001
crossref_primary_10_1016_j_genrep_2023_101790
crossref_primary_10_3390_cells10081892
crossref_primary_10_1016_j_jdermsci_2020_03_002
crossref_primary_10_1080_07391102_2022_2068650
crossref_primary_10_1080_21691401_2019_1669618
crossref_primary_10_1016_j_omtn_2020_06_025
crossref_primary_10_1111_jcmm_15088
crossref_primary_10_3390_antiox13010028
crossref_primary_10_3892_etm_2019_8052
crossref_primary_10_1016_j_ijbiomac_2024_137248
crossref_primary_10_1002_jcb_26217
crossref_primary_10_1016_j_omtn_2018_10_001
crossref_primary_10_18632_aging_202446
crossref_primary_10_1089_ars_2023_0253
crossref_primary_10_1016_j_yjmcc_2019_04_004
crossref_primary_10_1016_j_biopha_2019_109607
crossref_primary_10_1080_02713683_2021_2021586
crossref_primary_10_23950_jcmk_12662
crossref_primary_10_18632_oncotarget_23325
crossref_primary_10_3390_cancers16244239
crossref_primary_10_1007_s12015_022_10327_x
crossref_primary_10_1016_j_gene_2017_12_017
crossref_primary_10_3390_nu14214503
crossref_primary_10_3389_fmed_2020_00048
crossref_primary_10_18632_aging_203903
crossref_primary_10_1186_s43556_020_00004_1
crossref_primary_10_1038_s41419_019_1694_y
crossref_primary_10_1186_s13018_023_04003_0
crossref_primary_10_1093_nar_gkaa1017
crossref_primary_10_3748_wjg_v25_i35_5283
crossref_primary_10_1002_kjm2_12191
crossref_primary_10_1016_j_ncrna_2024_06_007
crossref_primary_10_1111_jgh_15657
crossref_primary_10_1186_s12645_023_00183_w
crossref_primary_10_1080_10408398_2021_2020720
crossref_primary_10_1002_jcp_29765
crossref_primary_10_1016_j_trsl_2020_05_010
crossref_primary_10_18632_oncotarget_19502
crossref_primary_10_1042_BCJ20200219
crossref_primary_10_1002_mc_23358
crossref_primary_10_3390_cells11152277
crossref_primary_10_1002_mgg3_1125
crossref_primary_10_1016_j_gene_2018_03_027
crossref_primary_10_3390_antiox9060468
crossref_primary_10_1002_jcp_28450
crossref_primary_10_1038_s41419_018_0282_x
crossref_primary_10_1272_jnms_JNMS_2018_86_402
crossref_primary_10_1177_1535370218804781
crossref_primary_10_3390_biomedicines10051212
crossref_primary_10_3892_ijo_2020_5047
crossref_primary_10_1016_j_neuroscience_2020_04_020
crossref_primary_10_1002_jcb_26273
crossref_primary_10_1016_j_prp_2024_155223
crossref_primary_10_1016_j_molimm_2018_11_011
crossref_primary_10_1002_jcp_27915
crossref_primary_10_1093_abbs_gmx048
crossref_primary_10_18632_aging_101999
crossref_primary_10_1080_08927022_2022_2055012
crossref_primary_10_3390_cells13231935
crossref_primary_10_1016_j_bbrc_2018_11_185
crossref_primary_10_1089_bio_2020_0088
crossref_primary_10_1016_j_jhep_2021_12_014
crossref_primary_10_1182_blood_2019000802
crossref_primary_10_1186_s13287_018_0861_x
crossref_primary_10_2174_1566524022666220509122505
crossref_primary_10_3389_fonc_2019_00649
crossref_primary_10_1590_1414_431x20198385
crossref_primary_10_3390_cells11060985
crossref_primary_10_1016_j_yexcr_2022_113340
crossref_primary_10_1155_2019_8626703
crossref_primary_10_14814_phy2_70160
crossref_primary_10_3727_096504017X15024935181289
crossref_primary_10_1007_s00018_019_03240_z
crossref_primary_10_1016_j_biopha_2019_109774
crossref_primary_10_1042_BSR20200740
crossref_primary_10_1155_2020_6069390
crossref_primary_10_1002_cac2_12109
crossref_primary_10_1089_ars_2017_7229
crossref_primary_10_1016_j_biopha_2018_02_134
crossref_primary_10_1097_MD_0000000000008583
crossref_primary_10_1080_07391102_2022_2103028
crossref_primary_10_1097_CM9_0000000000002722
crossref_primary_10_3390_ijms252212459
crossref_primary_10_1016_j_gene_2018_11_072
crossref_primary_10_1016_j_canlet_2021_08_004
crossref_primary_10_1080_15476286_2018_1493333
crossref_primary_10_3390_jcm9041200
crossref_primary_10_3389_fonc_2020_00285
crossref_primary_10_1111_jphp_13170
crossref_primary_10_1007_s10753_019_00995_2
crossref_primary_10_1016_j_bbadis_2017_06_014
crossref_primary_10_1155_2020_5976127
crossref_primary_10_1186_s13046_018_0994_x
crossref_primary_10_1152_ajpcell_00394_2020
crossref_primary_10_1016_j_gene_2018_05_096
crossref_primary_10_1080_15384101_2019_1598726
crossref_primary_10_3390_cells11162517
crossref_primary_10_2147_OTT_S291123
crossref_primary_10_1016_j_biopha_2023_114698
crossref_primary_10_1002_mog2_70000
crossref_primary_10_3390_cancers15174399
crossref_primary_10_1111_liv_14085
crossref_primary_10_4291_wjgp_v12_i5_84
crossref_primary_10_3892_ol_2018_9137
crossref_primary_10_1007_s11033_021_06680_8
crossref_primary_10_3389_fgene_2019_00918
crossref_primary_10_1111_febs_17253
crossref_primary_10_3389_fcell_2022_890605
crossref_primary_10_1016_j_neuroscience_2018_12_040
crossref_primary_10_1002_jcla_23656
crossref_primary_10_1097_SCS_0000000000007824
crossref_primary_10_1016_j_semcancer_2020_10_009
crossref_primary_10_18632_oncotarget_16880
crossref_primary_10_3892_mmr_2022_12878
crossref_primary_10_1016_j_neuroscience_2022_07_028
crossref_primary_10_1111_nyas_13612
crossref_primary_10_1093_abbs_gmx141
crossref_primary_10_3892_mmr_2018_8782
crossref_primary_10_3389_fimmu_2020_579687
crossref_primary_10_3390_cells9122613
crossref_primary_10_3389_fgene_2020_01015
crossref_primary_10_1002_hep_31765
crossref_primary_10_2174_1574892818666221207115016
crossref_primary_10_1111_cpr_12397
crossref_primary_10_1186_s12935_019_0866_2
crossref_primary_10_1371_journal_pone_0260103
crossref_primary_10_3389_fphys_2021_659638
crossref_primary_10_1002_cam4_1721
crossref_primary_10_1016_j_biopha_2018_11_065
crossref_primary_10_1016_j_biopha_2019_109222
crossref_primary_10_1186_s13045_017_0428_9
crossref_primary_10_1111_cas_14447
crossref_primary_10_1016_j_biopha_2018_03_083
crossref_primary_10_31083_j_fbl2808173
crossref_primary_10_3390_cells11010005
crossref_primary_10_3390_ijms26052194
crossref_primary_10_1007_s11605_021_05160_5
crossref_primary_10_1002_jcb_29222
crossref_primary_10_1186_s10020_020_00156_4
crossref_primary_10_1016_j_biopha_2021_111753
crossref_primary_10_1002_jcb_28531
crossref_primary_10_3389_fendo_2023_1238981
crossref_primary_10_1016_j_arcmed_2021_06_009
crossref_primary_10_1155_2019_1318795
crossref_primary_10_1155_2019_2601271
crossref_primary_10_1002_hep_31534
crossref_primary_10_1038_s41598_023_35167_8
crossref_primary_10_1186_s12864_018_5133_8
crossref_primary_10_1111_1440_1681_13283
crossref_primary_10_1080_21655979_2022_2074703
crossref_primary_10_1016_j_biochi_2019_04_006
crossref_primary_10_1152_ajpheart_00681_2024
crossref_primary_10_2217_epi_2018_0182
crossref_primary_10_3389_fcell_2022_838332
Cites_doi 10.1186/s13045-016-0288-8
10.1038/onc.2015.396
10.1007/s00432-008-0483-2
10.1007/s00018-016-2339-2
10.1016/j.freeradbiomed.2013.07.034
10.4049/jimmunol.178.6.3893
10.1016/j.taap.2014.10.022
10.1093/hmg/ddu040
10.1186/s13045-015-0129-1
10.1186/s13045-014-0063-7
10.1186/1471-2164-15-S9-S7
10.1002/ijc.21893
10.1023/A:1018822628096
10.1016/j.canlet.2013.01.033
10.1016/j.freeradbiomed.2010.09.006
10.1016/j.biocel.2014.02.022
10.1186/s13045-014-0090-4
10.1053/j.gastro.2013.10.013
10.1186/s13046-014-0103-8
10.1002/eji.201344126
10.3109/10715762.2016.1172071
10.1073/pnas.1310201110
10.1038/srep24141
10.3748/wjg.v20.i33.11630
10.3748/wjg.v20.i46.17324
10.1155/2012/630543
10.7554/eLife.01776
10.1097/00000658-199803000-00012
10.1093/nar/gkq285
10.1158/0008-5472.CAN-15-1443
10.1016/j.ccell.2015.02.004
10.1186/s12943-015-0458-2
10.1007/s10620-010-1481-1
10.1126/scisignal.6288er5
10.1007/s00408-016-9879-y
10.1186/s13045-015-0146-0
10.1093/carcin/bgh157
10.1038/nature17039
10.1002/hep.24563
10.1159/000430109
10.1016/j.molcel.2013.08.027
10.1074/jbc.M112.342113
10.1097/MOH.0000000000000002
10.1111/j.1600-0625.2011.01359.x
10.1073/pnas.161272598
10.1016/j.cellsig.2013.01.007
10.3748/wjg.v13.i10.1561
10.3748/wjg.v18.i29.3849
10.1111/cpr.12228
10.2353/ajpath.2006.050204
10.1155/2014/149185
10.1038/sj.onc.1210648
10.1016/j.jhep.2008.09.015
10.1152/ajprenal.00290.2015
10.1016/j.parint.2011.06.011
10.1007/s13277-013-0688-0
10.1186/s13073-015-0162-2
10.2174/1381612043384727
10.1515/BC.2006.049
10.1111/j.1742-4658.2012.08694.x
10.1126/science.1251456
10.1186/2050-7771-2-19
ContentType Journal Article
Copyright Copyright BioMed Central 2016
The Author(s). 2016
Copyright_xml – notice: Copyright BioMed Central 2016
– notice: The Author(s). 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s13045-016-0348-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-8722
EndPage 117
ExternalDocumentID oai_doaj_org_article_0fde27ed094f4941ba093ee1bf423be8
PMC5093965
4239632311
27809873
10_1186_s13045_016_0348_0
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
China
Japan
GeographicLocations_xml – name: China
– name: United States--US
– name: Japan
GrantInformation_xml – fundername: ;
  grantid: 2014A020212135 and 81270629
GroupedDBID ---
0R~
2WC
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
~8M
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c629t-f5d25d2fd5ffc348ec40ac75247b300f4a211cf3df6c06ccf9ba19c419c4f9fc3
IEDL.DBID 7X7
ISSN 1756-8722
IngestDate Wed Aug 27 01:30:05 EDT 2025
Thu Aug 21 18:23:37 EDT 2025
Fri Jul 11 06:49:09 EDT 2025
Fri Jul 25 06:49:05 EDT 2025
Thu Jan 02 23:08:22 EST 2025
Tue Jul 01 04:23:11 EDT 2025
Thu Apr 24 23:12:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Oxidative stress
ceRNA
Migration and invasion
Cholangiocarcinoma
Inflammation response
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c629t-f5d25d2fd5ffc348ec40ac75247b300f4a211cf3df6c06ccf9ba19c419c4f9fc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/1836252042?pq-origsite=%requestingapplication%
PMID 27809873
PQID 1836252042
PQPubID 54946
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_0fde27ed094f4941ba093ee1bf423be8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5093965
proquest_miscellaneous_1836729462
proquest_journals_1836252042
pubmed_primary_27809873
crossref_primary_10_1186_s13045_016_0348_0
crossref_citationtrail_10_1186_s13045_016_0348_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-11-03
PublicationDateYYYYMMDD 2016-11-03
PublicationDate_xml – month: 11
  year: 2016
  text: 2016-11-03
  day: 03
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of hematology and oncology
PublicationTitleAlternate J Hematol Oncol
PublicationYear 2016
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References Y Liu (348_CR12) 2015; 282
AN Kallen (348_CR39) 2013; 52
FO Carvalho de (348_CR65) 2016; 194
K Leelawat (348_CR53) 2007; 13
H Cui (348_CR10) 2014; 44
S Pinlaor (348_CR3) 2004; 25
P Monnier (348_CR58) 2013; 110
F Yang (348_CR59) 2012; 279
YJ Chen (348_CR19) 2012; 18
A Sanchez-Mejias (348_CR38) 2015; 8
D Uchida (348_CR37) 2016; 50
C Li (348_CR61) 2015; 36
JH Yu (348_CR66) 2014; 20
SY Kim (348_CR48) 2013; 25
K Fang (348_CR43) 2014; 23
E Raveh (348_CR56) 2015; 14
N Namwat (348_CR21) 2012; 13
F Virgilio Di (348_CR62) 2004; 10
R Thanan (348_CR63) 2013; 65
BW Han (348_CR25) 2013; 6
S Reuter (348_CR7) 2010; 49
C Voellenkle (348_CR29) 2016; 6
S Kawanishi (348_CR5) 2006; 387
A Prawan (348_CR67) 2009; 135
AA Yarmishyn (348_CR14) 2014; 15
M Luo (348_CR57) 2013; 333
348_CR64
IJ Matouk (348_CR55) 1843; 2014
HR Rosen (348_CR51) 1997; 42
M Krawczyk (348_CR11) 2014; 3
Y Chen (348_CR18) 2011; 56
KY Lin (348_CR49) 2016; 35
J Wang (348_CR27) 2010; 38
P Wang (348_CR42) 2014; 344
MD Huang (348_CR22) 2015; 8
P Chusorn (348_CR20) 2013; 34
S Pinlaor (348_CR6) 2006; 119
M Tarocchi (348_CR9) 2014; 20
S Rizvi (348_CR4) 2013; 145
J Lin (348_CR33) 2015; 309
G Fava (348_CR1) 2012; 2012
S Hummel (348_CR52) 2014; 21
T Minamino (348_CR35) 2001; 98
C Johnson (348_CR40) 2012; 1
G Landskron (348_CR47) 2014; 2014
N Iizuka (348_CR24) 2004; 24
AH Mirza (348_CR31) 2015; 7
S Zhao (348_CR41) 2014; 33
F Meng (348_CR17) 2008; 27
Y Fan (348_CR45) 2016; 9
TP Xu (348_CR44) 2014; 7
PJ McKiernan (348_CR32) 2014; 52
P Yongvanit (348_CR8) 2012; 61
V Oliveira-Marques de (348_CR34) 2007; 178
S Manca (348_CR13) 2011; 20
JS Goydos (348_CR50) 1998; 227
G Loewen (348_CR23) 2014; 7
Y Du (348_CR60) 2012; 287
M Karin (348_CR2) 2016; 529
G Li (348_CR28) 2014; 2014
PJ Mishra (348_CR16) 2014; 2
F Yang (348_CR26) 2011; 54
L Chen (348_CR15) 2009; 50
S Ohira (348_CR54) 2006; 168
B Liu (348_CR30) 2015; 27
S Kongpetch (348_CR36) 2016; 49
A Eichten (348_CR46) 2016; 76
17621267 - Oncogene. 2008 Jan 10;27(3):378-86
24275689 - Curr Opin Hematol. 2014 Jan;21(1):29-36
27063004 - Sci Rep. 2016 Apr 11;6:24141
21704729 - Parasitol Int. 2012 Mar;61(1):130-5
21994887 - Int J Hepatol. 2012;2012:630543
25759022 - Cancer Cell. 2015 Mar 9;27(3):370-81
25966845 - J Hematol Oncol. 2015 May 14;8:50
24901008 - J Immunol Res. 2014;2014:149185
24055342 - Mol Cell. 2013 Oct 10;52(1):101-12
15736456 - Anticancer Res. 2004 Nov-Dec;24(6):4085-9
26921327 - Cancer Res. 2016 Apr 15;76(8):2327-39
20423907 - Nucleic Acids Res. 2010 Sep;38(16):5366-83
25968300 - Cell Physiol Biochem. 2015;36(2):423-34
17339489 - J Immunol. 2007 Mar 15;178(6):3893-902
25522241 - BMC Genomics. 2014;15 Suppl 9:S7
23917144 - Free Radic Biol Med. 2013 Dec;65:1464-72
26791721 - Nature. 2016 Jan 21;529(7586):307-15
15134562 - Curr Pharm Des. 2004;10(14):1647-52
27439973 - J Hematol Oncol. 2016 Jul 21;9(1):57
25447409 - Toxicol Appl Pharmacol. 2015 Jan 1;282(1):9-19
16570287 - Int J Cancer. 2006 Sep 1;119(5):1067-72
22724089 - Transl Gastrointest Cancer. 2012 Apr 1;1(1):58-70
21913998 - Exp Dermatol. 2011 Nov;20(11):932-7
26536864 - Mol Cancer. 2015 Nov 04;14:184
26400545 - Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F901-13
24488769 - Hum Mol Genet. 2014 Jun 15;23(12):3278-88
11447290 - Proc Natl Acad Sci U S A. 2001 Jul 17;98 (15):8798-803
27113373 - Lung. 2016 Aug;194(4):487-99
25491133 - J Hematol Oncol. 2014 Dec 10;7:90
26726846 - Cell Prolif. 2016 Feb;49(1):90-101
22776265 - FEBS J. 2012 Sep;279(17):3159-65
25471741 - J Exp Clin Cancer Res. 2014 Dec 04;33:103
22876037 - World J Gastroenterol. 2012 Aug 7;18(29):3849-61
20840865 - Free Radic Biol Med. 2010 Dec 1;49(11):1603-16
25206269 - World J Gastroenterol. 2014 Sep 7;20(33):11630-40
26455324 - Oncogene. 2016 Jun 30;35(26):3376-86
24757675 - Biomed Res Int. 2014;2014:780521
22685290 - J Biol Chem. 2012 Jul 27;287(31):26302-11
19070389 - J Hepatol. 2009 Feb;50(2):358-69
15059927 - Carcinogenesis. 2004 Aug;25(8):1535-42
27021847 - Free Radic Res. 2016 Jul;50(7):732-43
24744378 - Science. 2014 Apr 18;344(6181):310-3
25888444 - J Hematol Oncol. 2015 Mar 28;8:30
16565491 - Am J Pathol. 2006 Apr;168(4):1155-68
18820947 - J Cancer Res Clin Oncol. 2009 Apr;135(4):515-22
24703882 - Biochim Biophys Acta. 2014 Jul;1843(7):1414-26
25167886 - J Hematol Oncol. 2014 Aug 29;7:63
23480766 - Asian Pac J Cancer Prev. 2012;13 Suppl:65-9
24140396 - Gastroenterology. 2013 Dec;145(6):1215-29
23417858 - Tumour Biol. 2013 Jun;34(3):1579-88
23354591 - Cancer Lett. 2013 Jun 10;333(2):213-21
9201097 - Dig Dis Sci. 1997 Jun;42(6):1290-4
25356314 - Biomark Res. 2014 Oct 22;2:19
25991924 - Genome Med. 2015 May 13;7(1):39
9527063 - Ann Surg. 1998 Mar;227(3):398-404
24297921 - Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20693-8
17461449 - World J Gastroenterol. 2007 Mar 14;13(10 ):1561-8
25516643 - World J Gastroenterol. 2014 Dec 14;20(46):17324-9
23962981 - Sci Signal. 2013 Aug 20;6(289):re5
27563706 - Cell Mol Life Sci. 2017 Feb;74(4):607-616
21086164 - Dig Dis Sci. 2011 Jun;56(6):1693-701
24723426 - Eur J Immunol. 2014 Jul;44(7):2085-95
23333246 - Cell Signal. 2013 Apr;25(4):961-9
21769904 - Hepatology. 2011 Nov;54(5):1679-89
24631641 - Int J Biochem Cell Biol. 2014 Jul;52:184-91
24843008 - Elife. 2014 Apr 29;3:e01776
16606333 - Biol Chem. 2006 Apr;387(4):365-72
References_xml – volume: 9
  start-page: 57
  year: 2016
  ident: 348_CR45
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-016-0288-8
– volume: 35
  start-page: 3376
  year: 2016
  ident: 348_CR49
  publication-title: Oncogene
  doi: 10.1038/onc.2015.396
– volume: 2014
  start-page: 1414
  year: 1843
  ident: 348_CR55
  publication-title: Biochim Biophys Acta
– volume: 135
  start-page: 515
  year: 2009
  ident: 348_CR67
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-008-0483-2
– ident: 348_CR64
  doi: 10.1007/s00018-016-2339-2
– volume: 65
  start-page: 1464
  year: 2013
  ident: 348_CR63
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2013.07.034
– volume: 178
  start-page: 3893
  year: 2007
  ident: 348_CR34
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.6.3893
– volume: 282
  start-page: 9
  year: 2015
  ident: 348_CR12
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2014.10.022
– volume: 23
  start-page: 3278
  year: 2014
  ident: 348_CR43
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddu040
– volume: 8
  start-page: 30
  year: 2015
  ident: 348_CR38
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-015-0129-1
– volume: 7
  start-page: 63
  year: 2014
  ident: 348_CR44
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-014-0063-7
– volume: 15
  start-page: S7
  issue: Suppl 9
  year: 2014
  ident: 348_CR14
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-15-S9-S7
– volume: 119
  start-page: 1067
  year: 2006
  ident: 348_CR6
  publication-title: Int J Cancer
  doi: 10.1002/ijc.21893
– volume: 42
  start-page: 1290
  year: 1997
  ident: 348_CR51
  publication-title: Dig Dis Sci
  doi: 10.1023/A:1018822628096
– volume: 333
  start-page: 213
  year: 2013
  ident: 348_CR57
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.01.033
– volume: 49
  start-page: 1603
  year: 2010
  ident: 348_CR7
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2010.09.006
– volume: 52
  start-page: 184
  year: 2014
  ident: 348_CR32
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2014.02.022
– volume: 24
  start-page: 4085
  year: 2004
  ident: 348_CR24
  publication-title: Anticancer Res
– volume: 7
  start-page: 90
  year: 2014
  ident: 348_CR23
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-014-0090-4
– volume: 145
  start-page: 1215
  year: 2013
  ident: 348_CR4
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2013.10.013
– volume: 33
  start-page: 103
  year: 2014
  ident: 348_CR41
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-014-0103-8
– volume: 44
  start-page: 2085
  year: 2014
  ident: 348_CR10
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201344126
– volume: 50
  start-page: 732
  year: 2016
  ident: 348_CR37
  publication-title: Free Radic Res
  doi: 10.3109/10715762.2016.1172071
– volume: 110
  start-page: 20693
  year: 2013
  ident: 348_CR58
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1310201110
– volume: 6
  start-page: 24141
  year: 2016
  ident: 348_CR29
  publication-title: Sci Rep
  doi: 10.1038/srep24141
– volume: 20
  start-page: 11630
  year: 2014
  ident: 348_CR9
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i33.11630
– volume: 20
  start-page: 17324
  year: 2014
  ident: 348_CR66
  publication-title: World J Gastroentero
  doi: 10.3748/wjg.v20.i46.17324
– volume: 2012
  start-page: 630543
  year: 2012
  ident: 348_CR1
  publication-title: Int J Hepatol
  doi: 10.1155/2012/630543
– volume: 3
  start-page: e1776
  year: 2014
  ident: 348_CR11
  publication-title: Elife
  doi: 10.7554/eLife.01776
– volume: 227
  start-page: 398
  year: 1998
  ident: 348_CR50
  publication-title: Ann Surg
  doi: 10.1097/00000658-199803000-00012
– volume: 38
  start-page: 5366
  year: 2010
  ident: 348_CR27
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkq285
– volume: 76
  start-page: 2327
  year: 2016
  ident: 348_CR46
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-1443
– volume: 27
  start-page: 370
  year: 2015
  ident: 348_CR30
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.02.004
– volume: 1
  start-page: 58
  year: 2012
  ident: 348_CR40
  publication-title: Transl Gastrointest Cancer
– volume: 14
  start-page: 184
  year: 2015
  ident: 348_CR56
  publication-title: Mol Cancer
  doi: 10.1186/s12943-015-0458-2
– volume: 56
  start-page: 1693
  year: 2011
  ident: 348_CR18
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-010-1481-1
– volume: 6
  start-page: e5
  year: 2013
  ident: 348_CR25
  publication-title: Sci Signal
  doi: 10.1126/scisignal.6288er5
– volume: 194
  start-page: 487
  year: 2016
  ident: 348_CR65
  publication-title: Lung
  doi: 10.1007/s00408-016-9879-y
– volume: 8
  start-page: 50
  year: 2015
  ident: 348_CR22
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-015-0146-0
– volume: 25
  start-page: 1535
  year: 2004
  ident: 348_CR3
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgh157
– volume: 529
  start-page: 307
  year: 2016
  ident: 348_CR2
  publication-title: Nature.
  doi: 10.1038/nature17039
– volume: 54
  start-page: 1679
  year: 2011
  ident: 348_CR26
  publication-title: Hepatology
  doi: 10.1002/hep.24563
– volume: 36
  start-page: 423
  year: 2015
  ident: 348_CR61
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000430109
– volume: 52
  start-page: 101
  year: 2013
  ident: 348_CR39
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2013.08.027
– volume: 287
  start-page: 26302
  year: 2012
  ident: 348_CR60
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.342113
– volume: 21
  start-page: 29
  year: 2014
  ident: 348_CR52
  publication-title: Curr Opin Hematol
  doi: 10.1097/MOH.0000000000000002
– volume: 20
  start-page: 932
  year: 2011
  ident: 348_CR13
  publication-title: Exp Dermatol
  doi: 10.1111/j.1600-0625.2011.01359.x
– volume: 98
  start-page: 8798
  year: 2001
  ident: 348_CR35
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.161272598
– volume: 25
  start-page: 961
  year: 2013
  ident: 348_CR48
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2013.01.007
– volume: 13
  start-page: 1561
  year: 2007
  ident: 348_CR53
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v13.i10.1561
– volume: 18
  start-page: 3849
  year: 2012
  ident: 348_CR19
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v18.i29.3849
– volume: 49
  start-page: 90
  year: 2016
  ident: 348_CR36
  publication-title: Cell Prolif
  doi: 10.1111/cpr.12228
– volume: 13
  start-page: 65
  issue: Suppl
  year: 2012
  ident: 348_CR21
  publication-title: Asian Pac J Cancer Prev
– volume: 168
  start-page: 1155
  year: 2006
  ident: 348_CR54
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.050204
– volume: 2014
  start-page: 780521
  year: 2014
  ident: 348_CR28
  publication-title: Biomed Res Int
– volume: 2014
  start-page: 149185
  year: 2014
  ident: 348_CR47
  publication-title: J Immunol Res
  doi: 10.1155/2014/149185
– volume: 27
  start-page: 378
  year: 2008
  ident: 348_CR17
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210648
– volume: 50
  start-page: 358
  year: 2009
  ident: 348_CR15
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2008.09.015
– volume: 309
  start-page: F901
  year: 2015
  ident: 348_CR33
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00290.2015
– volume: 61
  start-page: 130
  year: 2012
  ident: 348_CR8
  publication-title: Parasitol Int
  doi: 10.1016/j.parint.2011.06.011
– volume: 34
  start-page: 1579
  year: 2013
  ident: 348_CR20
  publication-title: Tumour Biol
  doi: 10.1007/s13277-013-0688-0
– volume: 7
  start-page: 39
  year: 2015
  ident: 348_CR31
  publication-title: Genome Med
  doi: 10.1186/s13073-015-0162-2
– volume: 10
  start-page: 1647
  year: 2004
  ident: 348_CR62
  publication-title: Curr Pharm Des
  doi: 10.2174/1381612043384727
– volume: 387
  start-page: 365
  year: 2006
  ident: 348_CR5
  publication-title: Biol Chem
  doi: 10.1515/BC.2006.049
– volume: 279
  start-page: 3159
  year: 2012
  ident: 348_CR59
  publication-title: FEBS J
  doi: 10.1111/j.1742-4658.2012.08694.x
– volume: 344
  start-page: 310
  year: 2014
  ident: 348_CR42
  publication-title: Science
  doi: 10.1126/science.1251456
– volume: 2
  start-page: 19
  year: 2014
  ident: 348_CR16
  publication-title: Biomark Res
  doi: 10.1186/2050-7771-2-19
– reference: 23354591 - Cancer Lett. 2013 Jun 10;333(2):213-21
– reference: 24843008 - Elife. 2014 Apr 29;3:e01776
– reference: 20423907 - Nucleic Acids Res. 2010 Sep;38(16):5366-83
– reference: 22724089 - Transl Gastrointest Cancer. 2012 Apr 1;1(1):58-70
– reference: 21086164 - Dig Dis Sci. 2011 Jun;56(6):1693-701
– reference: 25968300 - Cell Physiol Biochem. 2015;36(2):423-34
– reference: 27021847 - Free Radic Res. 2016 Jul;50(7):732-43
– reference: 26400545 - Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F901-13
– reference: 24631641 - Int J Biochem Cell Biol. 2014 Jul;52:184-91
– reference: 25991924 - Genome Med. 2015 May 13;7(1):39
– reference: 9527063 - Ann Surg. 1998 Mar;227(3):398-404
– reference: 26726846 - Cell Prolif. 2016 Feb;49(1):90-101
– reference: 17621267 - Oncogene. 2008 Jan 10;27(3):378-86
– reference: 25167886 - J Hematol Oncol. 2014 Aug 29;7:63
– reference: 23480766 - Asian Pac J Cancer Prev. 2012;13 Suppl:65-9
– reference: 11447290 - Proc Natl Acad Sci U S A. 2001 Jul 17;98 (15):8798-803
– reference: 24275689 - Curr Opin Hematol. 2014 Jan;21(1):29-36
– reference: 15059927 - Carcinogenesis. 2004 Aug;25(8):1535-42
– reference: 24055342 - Mol Cell. 2013 Oct 10;52(1):101-12
– reference: 23917144 - Free Radic Biol Med. 2013 Dec;65:1464-72
– reference: 20840865 - Free Radic Biol Med. 2010 Dec 1;49(11):1603-16
– reference: 26921327 - Cancer Res. 2016 Apr 15;76(8):2327-39
– reference: 17461449 - World J Gastroenterol. 2007 Mar 14;13(10 ):1561-8
– reference: 24703882 - Biochim Biophys Acta. 2014 Jul;1843(7):1414-26
– reference: 21913998 - Exp Dermatol. 2011 Nov;20(11):932-7
– reference: 24140396 - Gastroenterology. 2013 Dec;145(6):1215-29
– reference: 25206269 - World J Gastroenterol. 2014 Sep 7;20(33):11630-40
– reference: 24297921 - Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20693-8
– reference: 25888444 - J Hematol Oncol. 2015 Mar 28;8:30
– reference: 24488769 - Hum Mol Genet. 2014 Jun 15;23(12):3278-88
– reference: 25491133 - J Hematol Oncol. 2014 Dec 10;7:90
– reference: 22685290 - J Biol Chem. 2012 Jul 27;287(31):26302-11
– reference: 25447409 - Toxicol Appl Pharmacol. 2015 Jan 1;282(1):9-19
– reference: 16606333 - Biol Chem. 2006 Apr;387(4):365-72
– reference: 22876037 - World J Gastroenterol. 2012 Aug 7;18(29):3849-61
– reference: 24901008 - J Immunol Res. 2014;2014:149185
– reference: 25516643 - World J Gastroenterol. 2014 Dec 14;20(46):17324-9
– reference: 22776265 - FEBS J. 2012 Sep;279(17):3159-65
– reference: 24757675 - Biomed Res Int. 2014;2014:780521
– reference: 17339489 - J Immunol. 2007 Mar 15;178(6):3893-902
– reference: 26455324 - Oncogene. 2016 Jun 30;35(26):3376-86
– reference: 27063004 - Sci Rep. 2016 Apr 11;6:24141
– reference: 15134562 - Curr Pharm Des. 2004;10(14):1647-52
– reference: 26791721 - Nature. 2016 Jan 21;529(7586):307-15
– reference: 18820947 - J Cancer Res Clin Oncol. 2009 Apr;135(4):515-22
– reference: 27439973 - J Hematol Oncol. 2016 Jul 21;9(1):57
– reference: 27113373 - Lung. 2016 Aug;194(4):487-99
– reference: 27563706 - Cell Mol Life Sci. 2017 Feb;74(4):607-616
– reference: 16565491 - Am J Pathol. 2006 Apr;168(4):1155-68
– reference: 19070389 - J Hepatol. 2009 Feb;50(2):358-69
– reference: 25522241 - BMC Genomics. 2014;15 Suppl 9:S7
– reference: 24744378 - Science. 2014 Apr 18;344(6181):310-3
– reference: 21769904 - Hepatology. 2011 Nov;54(5):1679-89
– reference: 23333246 - Cell Signal. 2013 Apr;25(4):961-9
– reference: 21994887 - Int J Hepatol. 2012;2012:630543
– reference: 23962981 - Sci Signal. 2013 Aug 20;6(289):re5
– reference: 24723426 - Eur J Immunol. 2014 Jul;44(7):2085-95
– reference: 15736456 - Anticancer Res. 2004 Nov-Dec;24(6):4085-9
– reference: 25356314 - Biomark Res. 2014 Oct 22;2:19
– reference: 25471741 - J Exp Clin Cancer Res. 2014 Dec 04;33:103
– reference: 25966845 - J Hematol Oncol. 2015 May 14;8:50
– reference: 25759022 - Cancer Cell. 2015 Mar 9;27(3):370-81
– reference: 21704729 - Parasitol Int. 2012 Mar;61(1):130-5
– reference: 23417858 - Tumour Biol. 2013 Jun;34(3):1579-88
– reference: 16570287 - Int J Cancer. 2006 Sep 1;119(5):1067-72
– reference: 9201097 - Dig Dis Sci. 1997 Jun;42(6):1290-4
– reference: 26536864 - Mol Cancer. 2015 Nov 04;14:184
SSID ssj0061920
Score 2.5342343
Snippet Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in...
Background Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about...
BACKGROUNDLong non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about...
Abstract Background Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 117
SubjectTerms Biomarkers
Cell adhesion & migration
Cell cycle
Cell Line, Tumor
Cell Movement
ceRNA
Cholangiocarcinoma
Cholangiocarcinoma - etiology
Cholangiocarcinoma - genetics
Cholangiocarcinoma - pathology
Disease
Disease Progression
Hematology
Humans
Inflammation
Inflammation response
Interleukin-6 - genetics
MicroRNAs
Migration and invasion
Neoplasm Invasiveness
Oncology
Oxidative stress
Oxidative Stress - genetics
Pathogenesis
Proteins
Receptors, CXCR4 - genetics
RNA, Long Noncoding - metabolism
RNA, Long Noncoding - physiology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JLaZs-nKZBhZ5KTGRblqxjGhKWkuRQupCbkPVIDV1tyG5C8gP6vzsjeZdsKemlYIOxRpYsjWbm02OGkE_GBS-l68FyE23Jq74rDeg5nBKQVoFINB6B4tm5mEz514v24kGoL9wTlt0D54Y7YMH5WnoHMCRwBR8zgMG9r_oAhkDv0zFf0HkrMJVlMKKC1Rpm1YmDRYULggCbAT03vCvZhhZKzvr_ZmH-uVHygeY5eUGejyYjPcxVfUme-PiKPD0bF8W3ya_TaL-dHy7opFLUREcn09OjfYonFm7BknS0v6fzu8ElF980Hw7Zp1dpH56nOHNPZ8Nl5oSUf4i3BifR4IEm7BsvB1B511DcfGboGNqHGsgL5dKZwfBdr8n05Pj70aQcoyuUVtRqWYbW1XAF14ZgoVG85cxY2dZc9g1jgRvAhjY0LgjLhLVB9aZSluMdFGR5Q7biPPp3hHIgbBouuhbQXMDTsgFQiwmdk77mvioIW7W2tqPrcYyA8VMnCNIJnTtI43Yz7CDNCvJ5neUq-914jPgLduGaEF1mpxfASHpkJP0vRirI7ooB9DiOFxoEHgDEGiRbQT6uk2EEYueY6Oc3mQYgChdA8zbzy7omteyY6mRTELnBSRtV3UyJw4_k5RssuUaJdud__Nt78qxG5sfp8GaXbC2vb_wHMKaW_V4aN78BnhAdXg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Za9wwEBYhhdKX0rtu06BCn0rc-pAl66GUJCQsJZuH0oW8GVnH1pCV091NSH5A_3dn5INuWAI2GHsGC82MZj4dM4R8UsZZIUwNkRsvYpbWZazAz-GUgNAShkRlEShOz_lkxn5cFBc7ZChv1Xfgaiu0w3pSs-Xll9s_d9_B4L8Fgy_511WKy30AigEb56yMAcE_AscksKDBlI2LCggVhoXNrWwbrilk8N8Wdt7fPfmfOzp9Rp72cSQ97AT_nOxY_4I8nvYr5S_J3zOvf54frugklVR5Qyezs-MDiscYbiC8NLS-o-1tY0Leb9qdGDmgV2FznqU4nU8XzbxTj8Df-BuFM2vwQEOv-XkDfnAJv2sXivb1fqgCXvgvXSis6fWKzE5Pfh1P4r7kQqx5JtexK0wGlzOFcxo6xWqWKC2KjIk6TxLHFABG7XLjuE641k7WKpWa4e0ksLwmu7719i2hDAjznPGyAIjn8AitAyijXGmEzZhNI5IMvV3pPh85lsW4rAIuKXnVCajCPWgooCqJyOeR5apLxvEQ8RGKcCTEPNrhRbucV71ZVokzNhPWAMh1TIKqqkTm1qa1gzCztmVE9gYFqAbdrGAUBNSYwXAXkY_jZzBLFI7ytr3uaAC3MA40bzp9GVuSiTKRpcgjIjY0aaOpm1988zuk_obwLpe8ePdws96TJxmqNc5-53tkd728th8gdlrX-8Ei_gHPsxbx
  priority: 102
  providerName: Scholars Portal
Title LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner
URI https://www.ncbi.nlm.nih.gov/pubmed/27809873
https://www.proquest.com/docview/1836252042
https://www.proquest.com/docview/1836729462
https://pubmed.ncbi.nlm.nih.gov/PMC5093965
https://doaj.org/article/0fde27ed094f4941ba093ee1bf423be8
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ta9swEBZbC2Nfxt7nrQsa7NOoqV9kyf400tISQhNGt0C-GVkvmWGxsyQt2w_Y_96drHhNGYU4NvYJC98j6Z6TdEfIR6mtEUJXYLnxLGRxlYcSxjl0CQhVQJcoDRLFyZSPZmw8z-be4bbxyyp3faLrqHWr0Ed-AtADUz0BjH1e_QwxaxTOrvoUGg_JIYYuQ1SLeU-4kBvsZjLjnJ9sYpwWBPIMHDpleRjtjUUuZP__7My7yyVvjT8XT8kTbzjSYafpZ-SBaZ6TRxM_Nf6C_Lls1NV0uKGjuKCy0XQ0uzw7prhv4QbsSU2r37T9VWsX6Jt2W0SO6cqtxjMU_fd0WS86PLjydXMj0ZUGF9Qx4GZRw8C3hte1S0l9gh8qoSy8ly4lJvF6SWYX59_ORqHPsRAqnhTb0GY6gZ_VmbUKPopRLJJKZAkTVRpFlklgiMqm2nIVcaVsUcm4UAwPW0CRV-SgaRvzhlAGgmnKeJ4Bp7O4Z9YCd5E218IkzMQBiXZfu1Q-ADnmwfhROiKS87JTUImLzlBBZRSQT32RVRd94z7hU1RhL4iBs92Ndr0ofTssI6tNIowGVmtZAdiUUZEaE1cW7MrK5AE52gGg9K15U_7DXkA-9I-hHaJyZGPa604GiArjIPO6w0tfk0TkUZGLNCBiD0l7Vd1_0tTfXaxvsOfSgmdv76_WO_I4QVijuzs9Igfb9bV5D8bSthq4FjEgh8Ph-OsYzqfn0y9XA-d6gP8Jy_8CjMkY8Q
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXxOcIDDASvKBFcxwnTh4QGoOpY20f0Cr1LTj-KJFoUtpusD-Af4e_kbt8QRHa26RUippzbOXufPfz2XeEvFTGWSlNDp5bHPkiyBNfgZ3DJQGpU5gSlUWgOBrHg4n4OI2mW-RXdxYGt1V2c2I9UZtK4xr5PogeuOocZOzt4puPVaMwutqV0GjE4sRefAfItnpz_B74-4rzow-nhwO_rSrg65ina99FhsPlTOScDkVitWBKy4gLmYeMOaEAE2kXGhdrFmvt0lwFqRb4cyk0gfdeI9fB8DIEe3LaAzzEIl3kNEji_VWAYUgA64DZoSOfbdi-ukTA__zaf7dn_mXvju6Q262jSg8aybpLtmx5j9wYtaH4--TnsNSfxgcrOghSqkpDB5Ph4R7FcxLn4L8aml_Q6kdh6sTitDmSskcX9e4_SzFeQOfFrJG_un1RnitcuoMbWiPuclaAoV1Cd9Vc0bagEFXQFvqlc4VFwx6QyZV8_Ydku6xK-4hQAYRhKOIkAgzp8IyuA6ykXGKk5cIGHmHd1850m_Ac6258zWrgk8RZw6AMN7khgzLmkdd9k0WT7eMy4nfIwp4QE3XXf1TLWdbqfcacsVxaAyjaiRR0QbE0tDbIHfixuU08stsJQNbOHqvsj6x75EX_GPQemaNKW501NACMRAw0O4289CPhMmFpIkOPyA1J2hjq5pOy-FLnFgf_MUzj6PHlw3pObg5OR8NseDw-eUJucRRxXGoPd8n2enlmn4Kjts6f1dpByeerVsffj1ZS1Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LncRNAs+H19+and+HULC%2C+activated+by+oxidative+stress%2C+promote+cell+migration+and+invasion+in+cholangiocarcinoma+through+a+ceRNA+manner&rft.jtitle=Journal+of+hematology+and+oncology&rft.au=Wen-Tao%2C+Wang&rft.au=Ye%2C+Hua&rft.au=Pan-Pan%2C+Wei&rft.au=Bo-Wei%2C+Han&rft.date=2016-11-03&rft.pub=BioMed+Central&rft.eissn=1756-8722&rft.volume=9&rft_id=info:doi/10.1186%2Fs13045-016-0348-0&rft.externalDocID=4239632311
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-8722&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-8722&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-8722&client=summon